Combined cytotoxic and endocrine treatment of postmenopausal patients with advanced breast cancer: preliminary results of a phase II study of the combination of prednimustine, novantrone, methotrexate, 5-fluorouracil, and tamoxifen.

Source:http://linkedlifedata.com/resource/pubmed/id/3952520

Download in:

View as

General Info

PMID
3952520